Q4 2015 Holdings
Filed 2016-02-10 | 10 holdings | $179.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Juno Therapeutics | Common Stock | 48205A109 | $54.1K | 1,229,512 | 30.1% |
| Paratek Pharmaceuticals | Common Stock | 699374302 | $40.6K | 2,138,872 | 22.6% |
| Egalet | Common Stock | 28226B104 | $31.0K | 2,814,928 | 17.3% |
| FibroGen(FGENEUR) | Common Stock | 31572Q808 | $25.1K | 822,175 | 13.9% |
| Nabriva Therapeutics | Sponsored ADR | 62957M104 | $11.0K | 1,145,890 | 6.1% |
| Pieris Pharmaceuticals | Common Stock | 720795103 | $5.7K | 2,483,949 | 3.2% |
| Essa Pharma | Common Stock | 29668H104 | $4.6K | 1,090,909 | 2.6% |
| Proteon Therapeutics | Common Stock | 74371L109 | $3.9K | 250,000 | 2.2% |
| Dicerna Pharmaceuticals(DRNAUSD) | Common Stock | 253031108 | $2.7K | 223,457 | 1.5% |
| CymaBay Therapeutics(CBAYUSD) | Common Stock | 23257D103 | $1.1K | 650,000 | 0.6% |